title: Survival of various implant-supported prosthesis designs following 36 months of clinical function.
abstract: BACKGROUND
  The use of endosseous dental implants to replace natural teeth lost to trauma, dental caries, or periodontal disease has become a predictable form of prosthetic treatment since gaining popularity in the early 1980s. While numerous clinical studies have focused on the survival of implants, few address the survival of different prosthesis designs.
  
  
  METHODS
  Beginning in 1991, 882 prostheses supported by more than 2,900 implants (687 patients) were placed by the Department of Veterans Affairs Dental Implant Clinical Research Group (DICRG). These prostheses were divided into five research strata based on arch location. The recommended design for each stratum was: bar-supported overdenture (maxillary completely edentulous); screw-retained hybrid denture (mandibular completely edentulous); screw-retained fixed partial denture (mandibular and maxillary posterior partially edentulous); and cemented single crown (maxillary anterior single tooth). Alternative overdenture designs were utilized in the edentulous arches when the recommended prosthesis could not be fabricated. Prosthesis success rates for the research strata were calculated for an observation time of up to 36 months following prosthesis placement.
  
  
  RESULTS
  Success rates for the maxillary edentulous stratum ranged from 94.6% for the bar-retained overdenture supported by five to six fixtures to 81.8% for the cap-retained overdenture. The mandibular edentulous strata produced success rates of 98.1% for the fixed hybrid prosthesis to 91.7% for the cap-retained prosthesis. Success rates for maxillary and mandibular posterior fixed partial dentures were 94.3% and 92.6%, respectively, while the maxillary anterior single-tooth prosthesis yielded a success rate of 98.1% for the 36-month observation period.
  
  
  CONCLUSIONS
  The recommended prosthesis designs investigated in this study proved to be reliable, with encouraging success rates for an observation period of 36 months following placement.
authors.affiliation: VA Medical Center, Pittsburgh, PA, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Rodriguez
authors.forename: I H
authors.initials: IH
authors.lastname: Orenstein
authors.forename: H F
authors.initials: HF
authors.lastname: Morris
authors.forename: S
authors.initials: S
authors.lastname: Ochi
mesh_terms: D000497:Alloys; D020099:Coated Materials, Biocompatible; D003442:Crowns; D003722:Dental Alloys; D015921:Dental Implants; D019250:Dental Implants, Single-Tooth; D017267:Dental Prosthesis Design; D019094:Dental Prosthesis, Implant-Supported; D019232:Dental Restoration Failure; D003781:Denture Retention; D003826:Denture, Complete, Lower; D003827:Denture, Complete, Upper; D003828:Denture, Overlay; D003830:Denture, Partial, Fixed; D017886:Durapatite; D005500:Follow-Up Studies; D006801:Humans; D007575:Jaw, Edentulous / Q000534:rehabilitation; D007576:Jaw, Edentulous, Partially / Q000534:rehabilitation; D015993:Life Tables; D008334:Mandible / Q000473:pathology; D008437:Maxilla / Q000473:pathology; D011446:Prospective Studies; D015203:Reproducibility of Results; D016019:Survival Analysis; D014025:Titanium; D016896:Treatment Outcome
chemical_list: D000497:Alloys; D020099:Coated Materials, Biocompatible; D003722:Dental Alloys; D015921:Dental Implants; C031462:titanium alloy (TiAl6V4); D017886:Durapatite; D014025:Titanium